Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2022

European Healthtech startup funding raised during H1 2022.

In H1 2022, 325 European Healthtech companies closed 329 funding rounds and raised €4.1B in equity funding (excluding debt and grants), up 9.9% versus H1 2021. Debt rounds added €500M. France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.

Equity funding
€4.1B
+9.9% vs H1 2021 · excl. debt & grants · +€500M debt
Funding rounds
329
+41.8% vs H1 2021
Companies
325
Top country
France
Rank among sectors
#5
7.1% of sector funding
Debt financing
€500M
10.9% of total
Top-10 round share
29.4%
of disclosed capital
Rounds ≥ €100M
3

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2022 — interactive chart.
Data table
FundingRounds
Jan€1.0B65
Feb€790M60
Mar€916M46
Apr€475M44
May€529M47
Jun€927M67

Top countries

by € raised
Healthtech — top countries by capital, H1 2022 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2022
France€1.3B
UK€1.0B
Germany€479M
Switzerland€462M
Netherlands€392M
Spain€188M
Sweden€171M
Belgium€131M

Stage mix

by € raised
Healthtech — stage mix, H1 2022 — interactive chart.
Data table
Healthtech — stage mix, H1 2022
Other€1.5B
Series B€1.1B
Series A€899M
Debt€500M
Series C€249M
Seed€206M
Series D+€80M
Grant€17M
Pre-Seed€9.8M
Crowdfunding€2.5M

Exits & M&A

28 Acquisition · 1 IPO

29 exits · €7.7B disclosed.

Pharma IntelligenceAcquisitionFeb 2022€2.3B
NorgineAcquisitionJun 2022€1.8B
ZogenixAcquisitionJan 2022€1.7B
SPT LabtechAcquisitionJun 2022€757M
ReViralAcquisitionApr 2022€483M
NormaxIPOJun 2022€300M

Top deals

largest disclosed rounds in H1 2022
CompanyStageDateAmount
DoctolibDebtMar 2022€500M
Patient21OtherJan 2022€126M
Leyden LabsSeries BJan 2022€124M
Imcheck TherapeuticsOtherJun 2022€96M
MindMazeOtherFeb 2022€92M
OMass TherapeuticsSeries BApr 2022€90M
Ori BiotechSeries BJan 2022€88M
PadoaOtherFeb 2022€80M
PrecirixSeries BMar 2022€80M
DistalMotionSeries D+Jan 2022€80M
ProximieSeries CJun 2022€77M
Ambagon TherapeuticsSeries AJan 2022€75M
OwkinSeries BJun 2022€74M
DiabeloopOtherJun 2022€70M
Immunos TherapeuticsSeries BJun 2022€68M

Top investors

most active in H1 2022, by deal count